Feb
29
2024
FDA rejects Burlington biotech’s schizophrenia drug, sends stock tumbling – Boston Business Journal – The Business Journals
FDA rejects Burlington biotech’s schizophrenia drug, sends stock tumbling – Boston Business Journal The Business Journals